NCT02158689View on ClinicalTrials.gov

Comparison of Treatment Modalities in Poor Responders Undergoing IVF

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Poor Responders
Interventions
DRUG

Letrozole

DRUG

human menopausal gonadotropin (hMG)

Trial Locations (1)

34093

Department of Obstetrics and Gynecology, Istanbul University School of Medicine, Istanbul

All Listed Sponsors
lead

Ercan Bastu

OTHER

NCT02158689 - Comparison of Treatment Modalities in Poor Responders Undergoing IVF | Biotech Hunter | Biotech Hunter